VTRS Stock Analysis: Buy, Sell, or Hold?

VTRS - Viatris Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$13.83
0.36 (2.67%) ▲
5d: +3.13%
30d: +0.22%
90d: +8.39%
BUY
MODERATE Confidence
Analysis Updated: Apr 13, 2026 12:00 AM ET
Earnings: May 14, 2026 29d
Smart Money Distribution

VTRS is up 3.2% this week, but smart money is buying puts. Top strike: $13 2026-05-15 with 370 OI. Put ratio: 99% View Scanner →

Strength: 6.5/10

Get Alerted When VTRS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 0.4% decline. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$19.12
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$11.87
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.2x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VTRS is currently trading at $13.83, which is considered slightly high relative to its 30-day fair value range of $13.24 to $13.96. The stock's valuation (Forward PE: 5.2) is in line with its historical norms (5.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, VTRS is in a strong uptrend. The price is approaching resistance at $13.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: VTRS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.72 (+13.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $13.24 - $13.96
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 73.8%

All Signals

  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($15.72)

Fair Price Analysis

30-Day Fair Range $13.24 - $13.96
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $12.87
Resistance Level $13.79
Current Trend Strong Uptrend
Technical data as of Apr 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) 5.18
Wall Street Target $15.72 (+13.7%)
Revenue Growth (YoY) 5.0%
Earnings Growth (YoY) -70.6%
Profit Margin -24.6%
Valuation Discount vs History -0.4% cheaper
PE vs Historical 5.2 vs 5.2 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.4% (market-implied from PE analysis)
1-Year Target $13.77 (0%)
2-Year Target $13.72 (-1%)
3-Year Target $13.66 (-1%)
3-Yr Target (if PE normalizes) (PE: 5→5) $13.71 (-1%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.6, Growth: 9.3%) $71.73 (+419%)
Base: (SPY PE: 5.2, Growth: 9.3%) $18.08 (+31%)
Bear: (PE: 4.4, Growth: 9.3%) $15.37 (+11%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.2 to 5.2
Stabilization Target: $13.87 (+0.3%)
PE Expansion Potential: +0.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 13, 2026 7:32 PM ET
Data refreshes hourly during market hours. Next update: 8:32 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Paul Campbell SELL 21350 shares 2026-03-23
Gilbert Ray Cisneros, Jr. BUY 2025-11-18
David S Simmons BUY 213 shares 2025-11-03

Unlock Insider Activity

See real-time buying/selling by company executives for VTRS.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$185 60 HOLD
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$151 60 BUY
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$91 57 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$23 63 BUY
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 64 BUY

Advanced VTRS Option Strategies

Professional options setups generated by AI based on today's VTRS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for VTRS

VTRS Technical Chart VTRS Price Prediction VTRS Earnings Date VTRS Investment Advisor VTRS Fair Price Analyzer VTRS Options Advisor VTRS Options Chain VTRS Options Analysis VTRS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals